Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

X5050

😃Good
Catalog No. T39974Cas No. 2404756-81-4

X5050, a REST inhibitor, has an EC50 of 2.1 μM.

X5050

X5050

😃Good
Catalog No. T39974Cas No. 2404756-81-4
X5050, a REST inhibitor, has an EC50 of 2.1 μM.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
5 mg$2977-10 days7-10 days
1 mL x 10 mM (in DMSO)$2967-10 days7-10 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products. However, due to objective factors, there is a small probability that the synthesis may not be successful during the R&D process. We appreciate your understanding. If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
X5050, a REST inhibitor, has an EC50 of 2.1 μM.
In vitro
X5050 (100 μM, 1 day) induces a dosedependent decrease in the REST isoform in protein level[1]. Western Blot Analysis[1]Cell Line: NSCs. Concentration: 100 μM. Incubation Time: One day. Result: Induced a dosedependent decrease in the 122 kDa longer REST isoform.
In vivo
X5050, administered in two intraventricular injections (2 x 2µl of 20 mM) in a 10% DMSO aqueous solution, demonstrates activity in Huntington's Disease (HD) contexts. Utilizing 12-week-old male C57Bl6 mice as an animal model, the compound resulted in a significant increase in Brain-Derived Neurotrophic Factor (BDNF) expression, alongside a decrease in both Darpp32 and Snap25 expressions, as evidenced by Quantitative Reverse Transcription PCR (QRT-PCR) in the lesioned versus contralateral striatum. Additionally, it was observed that X5050 significantly elevated the levels of the Bdnf II splice variant, which contains exon II, whereas the levels of Bdnf IV splice variant remained unchanged.
Chemical Properties
Molecular Weight309.325
FormulaC17H15N3O3
Cas No.2404756-81-4
SmilesOc1ccccc1-c1nc2ccc(cc2[nH]1)C(=O)NOCC=C
Relative Density.1.323 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy X5050 | purchase X5050 | X5050 cost | order X5050 | X5050 chemical structure | X5050 in vivo | X5050 in vitro | X5050 formula | X5050 molecular weight